We would also like to take this opportunity to thank Varian Medical Systems and MedImmune;
Inc. for their financial support of this Supplement. These companies have had a long relationship with the RTOG;
one that has produced an enormous benefit to the entire radiation oncology community. This relationship demonstrates the critical need to foster the integration of government and industry resources in order to sustain the enormous progress of the last decade. This progress will translate into significant improvements in both survival and quality of life of cancer patients;